Disc Medicine Income Statement (2020-2026) | IRON

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
4.31M4.31M4.32M4.32M4.32M4.33M1.04M19.58M22.85M24.14M24.36M24.70M29.71M29.75M29.87M34.58M34.69M35.01M37.89M38.19M
Operating items
Research & Development (Quarter)
10.84M13.46M-10.91M7.82M7.71M7.89M10.02M20.18M12.10M14.42M22.57M23.70M23.48M24.68M24.80M27.76M46.32M50.33M46.22M45.90M
Selling, General & Administrative (Quarter)
5.48M5.00M-9.41M2.14M4.30M2.59M5.00M4.95M5.23M4.54M7.15M7.76M7.37M8.17M9.75M12.18M15.09M17.36M20.75M23.62M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
16.32M18.45M-20.33M9.96M12.02M10.48M15.02M25.12M17.33M18.96M29.71M31.46M30.85M32.86M34.55M39.95M61.41M67.70M66.97M69.52M
Operating Income (Quarter)
-16.32M-18.45M20.33M-9.96M-12.02M-10.48M-15.02M-25.12M-17.33M-18.96M-29.71M-31.46M-30.85M-32.86M-34.55M-39.95M-61.41M-67.70M-66.97M-69.52M
EBIT (Quarter)
-16.32M-18.45M20.33M-9.96M-12.02M-10.48M-15.02M-25.12M-17.33M-18.96M-29.71M-31.46M-30.85M-32.86M-34.55M-39.95M-61.41M-67.70M-66.97M-69.52M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.01M0.00M0.01M0.04M0.27M0.39M2.37M2.91M4.84M4.68M4.52M4.57M6.36M5.84M6.88M7.06M6.41M7.41M6.89M
Other Non Operating Income (Quarter)
-5.05M0.10M-5.94M-0.01M0.01M-0.01M-0.00M-0.01M0.01M0.00M-0.00M0.07M-0.02M-0.00M0.02M
Non Operating Income (Quarter)
0.11M2.44M-5.67M3.78M2.37M1.41M4.86M6.17M4.52M4.56M6.37M5.27M5.98M6.21M5.48M6.53M6.07M
Net income details
EBT (Quarter)
-16.41M-18.55M20.09M-9.85M-9.58M-16.15M-11.24M-22.76M-15.92M-14.10M-23.55M-26.94M-26.29M-26.48M-29.28M-33.97M-55.20M-62.22M-60.44M-63.45M
Tax Provisions (Quarter)
0.02M0.08M0.02M-0.00M0.06M0.11M0.35M0.10M-44.76M0.10M
Profit After Tax (Quarter)
-16.45M-18.55M18.08M-9.85M-9.58M-16.15M-11.24M-22.78M-15.95M-14.12M-23.58M-26.95M-26.35M-26.60M-29.46M-34.09M-55.25M-62.32M-60.53M-63.50M
Income from Continuing Operations (Quarter)
-16.41M-18.55M20.09M-9.85M-9.58M-16.15M-11.24M-22.78M-16.00M-14.12M-23.55M-26.94M-26.35M-26.60M-29.64M-33.97M-55.20M-62.32M-15.69M-63.55M
Consolidated Net Income (Quarter)
-16.41M-18.55M20.09M-9.85M-9.58M-16.15M-11.24M-22.78M-16.00M-14.12M-23.55M-26.94M-26.35M-26.60M-29.64M-33.97M-55.20M-62.32M-15.69M-63.55M
Income towards Parent Company (Quarter)
-16.41M-18.55M20.09M-9.85M-9.58M-16.15M-11.24M-22.78M-16.00M-14.12M-23.55M-26.94M-26.35M-26.60M-29.64M-33.97M-55.20M-62.32M-15.69M-63.55M
Net Income towards Common Stockholders (Quarter)
-16.45M-18.55M20.09M-9.85M-9.58M-16.15M-11.24M-22.78M-15.95M-14.12M-23.58M-26.95M-26.35M-26.60M-29.64M-33.97M-55.20M-62.32M-15.69M-63.55M
Additional items
EPS (Basic) (Quarter)
-3.82-4.304.98-2.28-2.22-3.73-10.82-1.20-0.74-0.58-1.06-1.09-1.03-0.89-1.07-1.02-1.58-1.77-0.44-1.65
EPS (Diluted) (Quarter)
-3.82-4.3022.87-10.67-2.22-3.73-10.82-1.20-0.74-0.58-1.06-1.09-1.03-0.89-1.07-1.02-1.58-1.77-0.44-1.65
Shares Outstanding (Quarter)
4.30M4.31M4.04M4.32M4.32M4.33M1.04M18.95M21.48M24.32M22.32M24.81M25.65M29.94M27.61M33.32M35.02M35.18M35.30M38.49M
Shares Outstanding (Diluted) (Quarter)
4.30M4.31M0.88M0.92M4.32M4.33M1.04M18.95M21.48M24.32M22.32M24.81M25.65M29.94M27.61M33.32M35.02M35.18M35.30M38.49M
EBITDA (Quarter)
-16.32M-18.45M20.33M-9.96M-12.02M-10.48M-15.02M-25.12M-17.33M-18.96M-29.71M-31.46M-30.85M-32.86M-34.55M-39.95M-61.41M-67.70M-66.97M-69.52M
Interest Expenses (Quarter)
0.10M0.10M0.24M0.10M0.10M0.04M0.09M28.07M82.59M86.19M-0.19M114.37M0.60M1.65M1.55M1.45M0.88M1.25M
Tax Rate (Quarter)
-0.10-0.48-0.140.00-0.23-0.43-1.21-0.1674.05-0.16